Analyst firm Gartner Tuesday released its report on global smartphone sales in Q2, which showed that Chinese companies are increasingly putting pressure on leading tech giants Samsung and Apple (AAPL). In a notable achievement, Huawei outstripped Apple to be the No. 2 smartphone vendor in the world, riding on the success of its Honor lineup and premium model P20 Pro.
While Samsung continued to be the leading smartphone OEM with a global market share of 19.3% in the second quarter, it was evident that the Chinese firms were creating a dent in its figures. During the same quarter last year, the Korean smartphone giant had a market share of 22.6%.
Meanwhile, Apple’s market share saw a slight dip to 11.9% from 12.1% in the year-ago period as sales remained relatively flat. It may be noted that Q2 is Apple’s slowest quarter, as iPhone fans await the grand September launch event.
However, Huawei probably took full advantage of this slowdown, raising its global market share during this period to 13.3% from just 9.8% a year ago. Huawei’s unit sales jumped 38.5% during the second quarter.
Adding to the Chinese assault was Xiaomi, whose market share rose from 5.8% to 8.8%. In a striking first-time achievement, both the Chinese smartphone companies together sold more devices than Samsung during the quarter.
Also See: Apple to launch three new iPhone X designs
OnePlus-parent Oppo, the fifth largest smartphone vendor in the world, also saw slight increases in its unit sales and market share.
Reports back the figures published a month ago by IDC and Canalys, both of which reported the same order of ranking, albeit slight changes in the data.
Most Popular
United Parcel Service (UPS) seems on track to regain lost strength
Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company